Psychotropic drugs and medical conditions /
Saved in:
| Imprint: | New York : Nova Biomedical, [2017] |
|---|---|
| Description: | 1 online resource |
| Language: | English |
| Series: | Psychiatry, theory, applications and treatments Psychiatry- theory, applications, and treatments series. |
| Subject: | |
| Format: | E-Resource Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/11677364 |
MARC
| LEADER | 00000cam a2200000Ii 4500 | ||
|---|---|---|---|
| 001 | 11677364 | ||
| 005 | 20210426223633.6 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 170626s2017 nyu ob 001 0 eng d | ||
| 020 | |a 9781536119589 |q (electronic bk.) | ||
| 020 | |a 153611958X |q (electronic bk.) | ||
| 020 | |z 9781536119381 | ||
| 035 | |a (OCoLC)991595808 | ||
| 035 | 9 | |a (OCLCCM-CC)991595808 | |
| 040 | |a N$T |b eng |e rda |e pn |c N$T |d N$T |d EBLCP |d OCLCF |d AGLDB |d IGB |d AUW |d BTN |d MHW |d INTCL |d SNK |d YDX |d G3B |d S8I |d S8J |d STF |d D6H |d N$T |d OCLCQ | ||
| 049 | |a MAIN | ||
| 050 | 4 | |a RM315 | |
| 072 | 7 | |a MED |x 105020 |2 bisacsh | |
| 245 | 0 | 0 | |a Psychotropic drugs and medical conditions / |c Faruk Uguz, editor. |
| 264 | 1 | |a New York : |b Nova Biomedical, |c [2017] | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Psychiatry, theory, applications and treatments | |
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Online resource; title from PDF title page (EBSCO, viewed June 27, 2017) | |
| 505 | 0 | |a Preface; Acknowledgments; Chapter 1; Hematological Effects of Psychotropic Medications; Abstract; Introduction; Antipsychotic Medications; Second Generation Antipsychotic Drugs; Clozapine; Olanzapine; Risperidone and Paliperidone: Short-Acting and Long-Acting; Quetiapine; Ziprasidone; Aripiprazole; Iloperidone, Asenapine, and Lurasidone; First Generation Antipsychotic Drugs; Phenothiazines; Butyrophenones; Mood Stabilizer Medications; Carbamazepine; Oxcarbazepine; Divalproex; Lamotrigine; Lithium; Gabapentin; Pregabalin; Topiramate; Antidepressant Drugs | |
| 505 | 8 | |a Selective Serotonin Reuptake InhibitorsBupropion; Selective Serotonin Norepinephrine Reuptake Inhibitors; Atypical Antidepressants; Tricyclic and Tetracyclic Antidepressants; Benzodiazepines; Buspirone; Management; Conclusion; References; Chapter 2; Psychotropic Drug-Induced Renal Toxicity and Electrolyte Imbalance; Abstract; Introduction; Role of Kidneys in Drug Metabolism and Homeostasis; Psychotropics Known to Cause Renal Impairment and Electrolyte Imbalance; Psychotropics Causing Renal Toxicity; Lithium; Reduced Urinary Concentrating Capacity; Effect on Glomerular Filtration Rate | |
| 505 | 8 | |a Development of Nephrogenic Diabetes Insipidus (NDI)Other Renal Effects of Lithium; Antidepressants; Antipsychotics; Psychotropics Causing Electrolyte Imbalance; Psychotropic-Induced Hyponatremia (Table 3); Antidepressants; Antipsychotics; Mood Stabilizers; Psychotropic-Induced Hypernatremia (Table 4); Psychotropic-Induced Hypokalemia (Table 4); Antidepressants; Antipsychotics; Mood Stabilizers; Psychotropic-Induced Hyperkalemia (Table 4); Psychotropic-Induced Hypocalcemia (Table 4); Psychotropic-Induced Hypercalcemia (Table 4) | |
| 505 | 8 | |a Risk Factors of Psychotropic Induced Renal Impairment and Electrolyte ImbalanceAge; Gender; Physical Health and Co-Morbid Physical Illness; History of Hyponatremia/Electrolyte Disturbances in the Past; Nature of Psychiatry Disorder; Use of Other Concomitant Medications; Dose of Psychotropic Drug Used; Duration of Treatment; How to Prevent?; Psychotropic-Induced Renal Impairment; Psychotropic-induced Electrolyte Imbalance; Management; Management of Psychotropic-induced Renal Impairment Due to Rhabdomyolysis; Management of Lithium-induced Nephrogenic Diabetes Insipidus (NDI) | |
| 505 | 8 | |a Management of Lithium-Induced NephropathyTreatment of Lithium Toxicity and When to Go for Dialysis?; Psychotropic-Induced Electrolyte Imbalances; Hyponatremia; Management of Other Psychotropic-induced Electrolyte Imbalances; Conclusion; References; Chapter 3; Psychotropic Drug-Induced Hepatotoxicity; Abstract; Introduction; Antidepressants; Monoamine Oxidase (MAO) Inhibitors; Tricyclic Antidepressants; Selective Serotonin Reuptake Inhibitors; Serotonin Noradrenaline Reuptake Inhibitors; New Generation Antidepressants; Antipsychotic Agents; First Generation Antipsychotics (FGAs) | |
| 650 | 0 | |a Psychotropic drugs. |0 http://id.loc.gov/authorities/subjects/sh85108528 | |
| 650 | 7 | |a MEDICAL |x Psychiatry |x Psychopharmacology. |2 bisacsh | |
| 650 | 7 | |a Psychotropic drugs. |2 fast |0 (OCoLC)fst01081826 | |
| 655 | 4 | |a Electronic books. | |
| 700 | 1 | |a Uguz, Faruk, |e editor. | |
| 830 | 0 | |a Psychiatry- theory, applications, and treatments series. |0 http://id.loc.gov/authorities/names/n2009185501 | |
| 903 | |a HeVa | ||
| 929 | |a oclccm | ||
| 999 | f | f | |i 0e352552-c504-5b97-ad1a-1966b6dd1679 |s c7340c38-8f47-5cf9-b8c5-7340158a11ae |
| 928 | |t Library of Congress classification |a RM315 |l Online |c UC-FullText |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=1540037 |z eBooks on EBSCOhost |g ebooks |i 12454106 | ||